Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-st segment elevation myocardial infarction (from the National Cardiovascular Data Registry)

American Journal of Cardiology

Volumn 112, Issue 8, 2013, Pages 1057-1062

  Acharjee, Subroto ^a   Roe, Matthew T ^b   Amsterdam, Ezra A ^c   Holmes, Dajuanicia N ^d   Boden, William E ^e  

^a EINSTEIN MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; DATA BASE; DIABETES MELLITUS; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; UNITED STATES;

AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; DIAGNOSTIC TESTS, ROUTINE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84884902098     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.05.050     Document Type: Article

References (17)

1. H. Jafri, A.A. Alsheikh-Ali, and R.H. Karas Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk Ann Intern Med 153 2010 800 808
2. W.P. Castelli, R.J. Garrison, P.W. Wilson, R.D. Abbott, S. Kalousdian, and W.B. Kannel Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study JAMA 256 1986 2835 2838
3. G. Assmann, H. Schulte, A. von Eckardstein, and Y. Huang High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport Atherosclerosis 124 Suppl 1996 S11 S20
4. B.G. Choi, G. Vilahur, D. Yadegar, J.F. Viles-Gonzalez, and J.J. Badimon The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular disease Curr Mol Med 6 2006 571 587
5. K.K. Ray, C.P. Cannon, and P. Ganz Beyond lipid lowering: what have we learned about the benefits of statins from the acute coronary syndromes trials? Am J Cardiol 98 2006 S18 S25
6. E.D. Peterson, M.T. Roe, J.S. Rumsfeld, R.E. Shaw, R.G. Brindis, G.C. Fonarow, and C.P. Cannon A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction Circ Cardiovasc Qual Outcomes 2 2009 491 499
7. S. Zeger, and K. Liang Longitudinal data analysis for discrete and continuous outcomes Biometrics 42 1986 121 130
8. C.T. Chin, A.Y. Chen, T.Y. Wang, K.P. Alexander, R. Mathews, J.S. Rumsfeld, C.P. Cannon, G.C. Fonarow, E.D. Peterson, and M.T. Roe Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: the acute coronary treatment and intervention outcomes network (ACTION) registry-get with the guidelines (GWTG) acute myocardial infarction mortality model and risk score Am Heart J 161 2011 113 122
9. A. Sachdeva, C.P. Cannon, P.C. Deedwania, K.A. Labresh, S.C. Smith Jr., D. Dai, A. Hernandez, and G.C. Fonarow Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines Am Heart J 157 2009 111 117
10. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr., and N.J. Stone National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
11. M.T. Roe, F.S. Ou, K.P. Alexander, L.K. Newby, J.M. Foody, W.B. Gibler, W.E. Boden, E.M. Ohman, S.C. Smith Jr., and E.D. Peterson Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 29 2008 2480 2488
12. K.J. Sattler, J. Herrmann, S. Yün, N. Lehmann, Z. Wang, G. Heusch, S. Sack, R. Erbel, and B. Levkau High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention Eur Heart J 30 2009 1894 1902
13. K. Alwaili, D. Bailey, Z. Awan, S.D. Bailey, I. Ruel, A. Hafiane, L. Krimbou, S. Laboissiere, and J. Genest The HDL proteome in acute coronary syndromes shifts to an inflammatory profile Biochim Biophys Acta 1821 2012 405 415
14. T. Fyfe, R.H. Baxter, K.M. Cochran, and E.M. Booth Plasma-lipid changes after myocardial infarction Lancet 2 1971 997 1001
15. R.E. Ryder, T.M. Hayes, I.P. Mulligan, J.C. Kingswood, S. Williams, and D.R. Owens How soon after myocardial infarction should plasma lipid values be assessed? BMJ 289 1984 1651 1653
16. B. Pitt, J. Loscalzo, J. Yas, and J.S. Raichlen Lipid levels after acute coronary syndromes J Am Coll Cardiol 51 2008 1440 1445
17. J.H. Barth, B.M. Jackson, A.J. Farrin, M. Efthymiou, G. Worthy, J. Copeland, K.M. Bailey, S.P. Romaine, A.J. Balmforth, T. McCormack, A. Whitehead, M.D. Flather, J. Nixon, and A.S. Hall SPACE ROCKET Trial Group. Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review Clin Chem 56 2010 1592 1598